NX Prenatal is a private, U.S.-based molecular diagnostics company developing diagnostic assays for adverse pregnancy conditions such as pre-term birth. It employs the proprietary NeXosome® platform, which enables advanced isolation and enrichment of exosome and microvesicle particles from bodily fluids for non-invasive biomarker evaluation. NX Prenatal is planning the U.S. launch of the NeXosome Preterm Birth Risk Assay, which detects a new library of biomarkers for prenatal risk assessment as early as 10 weeks gestation. This technology may provide physicians an ideal opportunity to intervene in a timely manner with protocols for at-risk pregnancies in an attempt to reduce the likelihood of a preterm birth or minimize the complications that can arise for both the child and the mother.
Employees: 1-10
Founded date: 2013
Investors 4
Date | Name | Website |
- | Keyhorse C... | keyhorse.v... |
- | Mindshift ... | mindshiftc... |
- | VisionTech... | visiontech... |
- | XLerateHea... | xleratehea... |
Mentions in press and media 4
Date | Title | Description | Source |
18.04.2024 | NX Prenatal Appoints Paul Kortschak to Serve as Chief Execut... | LOUISVILLE, KY, UNITED STATES, April 18, 2024 /EINPresswire.com/ -- NX Prenatal, a leading women’s h... | einpresswi... |
18.01.2023 | NX Prenatal Announces Addition of Dr. Robert Bonebrake to St... | Robert G. Bonebrake, MD, FACOG LOUISVILLE, KY, USA, January 18, 2023 /EINPresswire.com/ -- NX Prenat... | einpresswi... |
05.01.2023 | NX Prenatal Announces Breakthrough Findings for the Detectio... | Exosome-Based Liquid Biopsy Detection of Placenta Accreta Spectrum Pregnant Moms with Prior C-Sectio... | einpresswi... |
01.11.2022 | NX Prenatal Named as an Awardee in Maternal-Fetal Immune Dis... | Pregnancy Outcomes LOUISVILLE, KY, UNITED STATES, November 1, 2022 /EINPresswire.com/ -- NX Prenatal... | einpresswi... |